NDC 0002-7910
Bamlanivimab
Bamlanivimab
Bamlanivimab is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Eli Lilly And Company. The primary component is Bamlanivimab.
| Product ID | 0002-7910_36913f45-d0a8-49b6-af0f-dd67299c2e96 |
| NDC | 0002-7910 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Bamlanivimab |
| Generic Name | Bamlanivimab |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2020-11-09 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | Eli Lilly and Company |
| Substance Name | BAMLANIVIMAB |
| Active Ingredient Strength | 35 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |